€32.7m market cap
€0.83 last close
Based in Spain, ADL Bionatur Solutions provides contract manufacturing of fermentation-based biochem products and antibiotics. It also develops and licenses its own portfolio of OTC and prescription animal health products, including probiotics and vaccines.
Investment summary
ADL Bionatur Solutions provides contract manufacturing (CMO) of fermentation-based products and services focused on the health, beauty and wellness sectors. It has established CMO/active pharmaceutical ingredient business lines and its own development line of innovative products. ADL has 2,400m3 of total fermentation capacity available and reported 2019 results of €45m in revenue and positive adjusted EBITDA.
Y/E Dec |
Revenue (€m) |
EBITDA (€m) |
PBT (€m) |
EPS (c) |
P/E (x) |
P/CF (x) |
|---|---|---|---|---|---|---|
| 2017A | 12.8 | (10.4) | (12.7) | (251.65) | N/A | N/A |
| 2018A | 25.3 | (12.5) | (16.3) | (43.16) | N/A | N/A |
| 2019E | 53.0 | 3.8 | (1.6) | (4.06) | N/A | N/A |
| 2020E | 71.6 | 10.5 | 4.2 | 10.76 | 7.7 | 3.8 |
Industry outlook
We estimate that ADL’s solid pipeline of CMO contracts will contribute to sustainable long-term growth, although 2020 results may be affected by COVID-19. We calculate ADL’s year-end 2019 net debt to be approximately €66.5m, including an €8.7m loan from its majority shareholder, BTC. The company is seeking to refinance €25m of its debt (which is held by Kartesia), and it may shortly receive a €10m cash injection from BTC and potential co-investors.
Last updated on 11/08/2020
Sector |
|---|
| Healthcare |
Share price graph
Balance sheet |
|
|---|---|
| Forecast net debt (€m) | 65.3 |
| Forecast gearing ratio (%) | 277 |
Price performance
% |
1m |
3m |
12m |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
| *% relative to local index | |||||||||||||||
Key management |
|
|---|---|
| Blanca San Roman | Head of IR |
You may also be interested in…
- 4SC
- Abliva
- Acacia Pharma
- Acarix
- Adocia
- Allarity Therapeutics
- ASIT biotech
- Basilea Pharmaceutica
- BerGenBio
- BioPorto Diagnostics
- Bonesupport
- Brighter
- Cantargia
- Carmat
- Celyad
- Deinove
- Formycon
- Herantis Pharma
- Hybrigenics
- Immunicum
- Immunovia
- Kiadis Pharma
- Laboratorios Farmacéuticos ROVI
- MagForce
- Medigene
- MOLOGEN
- Nanobiotix
- Newron Pharmaceuticals
- Nicox
- Nuevolution
- Oasmia Pharmaceutical
- Onxeo
- Orexo
- Oryzon Genomics
- OSE Immunotherapeutics
- Paion
- Pharnext
- Photocure
- Pixium Vision
- Polyphor
- Probiodrug
- Quantum Genomics
- RhoVac
- Ryvu Therapeutics
- Targovax
- Transgene
- TxCell
- Xbrane Biopharma